scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029569656 |
P356 | DOI | 10.1038/NATURE08703 |
P932 | PMC publication ID | 2813891 |
P698 | PubMed publication ID | 20072129 |
P5875 | ResearchGate publication ID | 41013405 |
P50 | author | Erik J. Sontheimer | Q37391329 |
P2093 | author name string | Luciano A Marraffini | |
P2860 | cites work | A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes | Q21090166 |
A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action | Q21203780 | ||
The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats | Q21284230 | ||
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes | Q21508827 | ||
Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain | Q22065445 | ||
Identification of 86 candidates for small non-messenger RNAs from the archaeon Archaeoglobus fulgidus. | Q24530580 | ||
Small CRISPR RNAs guide antiviral defense in prokaryotes | Q28290898 | ||
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus | Q28300379 | ||
CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea | Q29614740 | ||
CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA | Q29615786 | ||
Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements | Q29615788 | ||
Identification of genes that are associated with DNA repeats in prokaryotes | Q29615790 | ||
Phage response to CRISPR-encoded resistance in Streptococcus thermophilus | Q29617060 | ||
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin | Q29617073 | ||
Identification of novel non-coding RNAs as potential antisense regulators in the archaeon Sulfolobus solfataricus | Q31142371 | ||
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. | Q33985645 | ||
A putative viral defence mechanism in archaeal cells | Q33998177 | ||
Virus population dynamics and acquired virus resistance in natural microbial communities | Q34780702 | ||
Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus | Q34868607 | ||
Distribution of CRISPR spacer matches in viruses and plasmids of crenarchaeal acidothermophiles and implications for their inhibitory mechanism. | Q34921482 | ||
CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties | Q34951113 | ||
Short motif sequences determine the targets of the prokaryotic CRISPR defence system | Q34953078 | ||
Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages | Q34977088 | ||
Characterization of a conjugative staphylococcal mupirocin resistance plasmid | Q35115167 | ||
Identification and characterization of the origin of conjugative transfer (oriT) and a gene (nes) encoding a single-stranded endonuclease on the staphylococcal plasmid pGO1. | Q35611166 | ||
Carbodiimide-mediated cross-linking of RNA to nylon membranes improves the detection of siRNA, miRNA and piRNA by northern blot | Q35829307 | ||
Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance | Q36310190 | ||
CRISPR-based adaptive and heritable immunity in prokaryotes | Q37568446 | ||
Analysis of CRISPR system function in plant pathogen Xanthomonas oryzae. | Q43872652 | ||
Sorting of protein a to the staphylococcal cell wall | Q44656446 | ||
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus | Q44674318 | ||
The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage | Q45267220 | ||
Allelic replacement in Staphylococcus aureus with inducible counter-selection. | Q46624193 | ||
Thermodynamics-structure relationship of single mismatches in RNA/DNA duplexes | Q74311706 | ||
P433 | issue | 7280 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | CRISPR | Q412563 |
P304 | page(s) | 568-571 | |
P577 | publication date | 2010-01-13 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Self versus non-self discrimination during CRISPR RNA-directed immunity | |
P478 | volume | 463 |
Q29994612 | A CRISPR toolbox to study virus-host interactions |
Q35735544 | A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses |
Q24669850 | A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity |
Q58708478 | A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding |
Q27666531 | A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair |
Q34322670 | A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. |
Q64079526 | A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity |
Q40420402 | A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction |
Q38204896 | A versatile framework for microbial engineering using synthetic non-coding RNAs |
Q38763260 | Adaptation in CRISPR-Cas Systems |
Q38210066 | Adapting to new threats: the generation of memory by CRISPR-Cas immune systems |
Q43097718 | An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference. |
Q36286108 | An archaeal immune system can detect multiple protospacer adjacent motifs (PAMs) to target invader DNA. |
Q38947491 | Applications of CRISPR Genome Engineering in Cell Biology |
Q90402371 | Are aggressive epithelial cancers 'a disease' of Eutherian mammals? |
Q57970482 | Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications |
Q28657639 | Bacterial genome instability |
Q34034778 | Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. |
Q34021879 | Bacteriophage resistance mechanisms |
Q34210424 | Binding and cleavage of CRISPR RNA by Cas6 |
Q96304850 | Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes |
Q34509196 | Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering |
Q36603869 | Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system |
Q92648241 | Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance |
Q40076357 | Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape |
Q34529451 | C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector |
Q24628207 | CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III |
Q64063933 | CRISPR Spacers Indicate Preferential Matching of Specific Virioplankton Genes |
Q42694962 | CRISPR Technology Reveals RAD(51)-ical Mechanisms of Repair in Roundworms: An Educational Primer for Use with "Promotion of Homologous Recombination by SWS-1 in Complex with RAD-51 Paralogs in Caenorhabditis elegans". |
Q42544844 | CRISPR decoys: competitive inhibitors of CRISPR immunity |
Q36370849 | CRISPR interference and priming varies with individual spacer sequences |
Q34256881 | CRISPR interference directs strand specific spacer acquisition |
Q29617488 | CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea |
Q26824296 | CRISPR interference: a structural perspective |
Q37970501 | CRISPR loci reveal networks of gene exchange in archaea |
Q58568511 | CRISPR-Based Technologies: Impact of RNA-Targeting Systems |
Q89620887 | CRISPR-Cas Systems and the Paradox of Self-Targeting Spacers |
Q57166586 | CRISPR-Cas guides the future of genetic engineering |
Q34045076 | CRISPR-Cas immunity in prokaryotes |
Q38196778 | CRISPR-Cas system: a powerful tool for genome engineering |
Q34470094 | CRISPR-Cas systems in the marine actinomycete Salinispora: linkages with phage defense, microdiversity and biogeography. |
Q34040445 | CRISPR-Cas systems: beyond adaptive immunity |
Q40694770 | CRISPR-Cas-like system in giant viruses: why MIMIVIRE is not likely to be an adaptive immune system |
Q39219057 | CRISPR-Cas9 Structures and Mechanisms |
Q36149464 | CRISPR-Cas9-mediated genome editing and guide RNA design |
Q28069426 | CRISPR-Cas: biology, mechanisms and relevance |
Q24609425 | CRISPR-based adaptive immune systems |
Q37832252 | CRISPR-based immune systems of the Sulfolobales: complexity and diversity |
Q27027325 | CRISPR-mediated defense mechanisms in the hyperthermophilic archaeal genus Sulfolobus |
Q28751775 | CRISPR-mediated phage resistance and the ghost of coevolution past |
Q39094038 | CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus |
Q34330105 | CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli |
Q39105613 | CRISPR/Cas 9 genome editing and its applications in organoids |
Q52423173 | CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos. |
Q62029120 | CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology |
Q37079810 | CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. |
Q92933245 | Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex |
Q24564294 | Cas9 as a versatile tool for engineering biology |
Q93137464 | Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence |
Q36581178 | Characterization of CRISPR RNA biogenesis and Cas6 cleavage-mediated inhibition of a provirus in the haloarchaeon Haloferax mediterranei |
Q94923711 | Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase |
Q35943228 | Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax |
Q59656961 | Characterizing the activity of abundant, diverse and active CRISPR-Cas systems in lactobacilli |
Q98575566 | Chemistry of Class 1 CRISPR-Cas effectors: binding, editing, and regulation |
Q47142216 | Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus |
Q47820998 | Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System. |
Q37835849 | Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes |
Q40955079 | Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity |
Q37127428 | Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence. |
Q38044859 | Coevolution of bacteria and their viruses |
Q28550422 | Comparative Genomic Analysis of Mannheimia haemolytica from Bovine Sources |
Q36117572 | Comparative genomic analysis identifies structural features of CRISPR-Cas systems in Riemerella anatipestifer |
Q52422515 | Comparative genomic structures of Mycobacterium CRISPR-Cas. |
Q22065483 | Complete Genome Sequence of Methanothermobacter marburgensis, a Methanoarchaeon Model Organism |
Q34519053 | Conditional Control of CRISPR/Cas9 Function. |
Q41760159 | Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting |
Q39395687 | Conformational regulation of CRISPR-associated nucleases |
Q41117777 | Conjugation Assay for Testing CRISPR-Cas Anti-plasmid Immunity in Staphylococci |
Q40258509 | Conserved DNA motifs in the type II-A CRISPR leader region |
Q64056380 | Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition |
Q36206456 | Coupling immunity and programmed cell suicide in prokaryotes: Life-or-death choices |
Q27679265 | Crystal Structure of the Largest Subunit of a Bacterial RNA-guided Immune Complex and Its Role in DNA Target Binding |
Q27682287 | Crystal structure and nucleic acid-binding activity of the CRISPR-associated protein Csx1 of Pyrococcus furiosus |
Q35044142 | Crystal structure of Thermobifida fusca Cse1 reveals target DNA binding site |
Q26783837 | Current and future prospects for CRISPR-based tools in bacteria |
Q38282014 | Cutting it close: CRISPR-associated endoribonuclease structure and function |
Q38454128 | DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes |
Q33557550 | DNA binding specificities of Escherichia coli Cas1-Cas2 integrase drive its recruitment at the CRISPR locus |
Q33931841 | DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. |
Q37143400 | DNA motifs determining the efficiency of adaptation into the Escherichia coli CRISPR array |
Q98172325 | DNA targeting and interference by a bacterial Argonaute nuclease |
Q52422374 | Dangerous weapons: a cautionary tale of CRISPR defence. |
Q34038379 | Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids |
Q39028967 | Deciphering, Communicating, and Engineering the CRISPR PAM. |
Q28241526 | Development and applications of CRISPR-Cas9 for genome engineering |
Q38428813 | Direct detection of chicken genomic DNA for gender determination by thymine-DNA glycosylase |
Q47365243 | Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications. |
Q34536517 | Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems |
Q26741960 | Diversity of CRISPR-Cas-Mediated Mechanisms of Adaptive Immunity in Prokaryotes and Their Application in Biotechnology |
Q38178215 | Do all creatures possess an acquired immune system of some sort? |
Q34155448 | Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers |
Q90025185 | Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity |
Q30252615 | Dynamics of adaptive immunity against phage in bacterial populations. |
Q92224257 | Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a |
Q55408150 | Editorial: Genome Invading RNA Networks. |
Q40628722 | Efficient CRISPR-Mediated Post-Transcriptional Gene Silencing in a Hyperthermophilic Archaeon Using Multiplexed crRNA Expression. |
Q35968268 | Efficient identification of CRISPR/Cas9-induced insertions/deletions by direct germline screening in zebrafish |
Q35914859 | Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. |
Q34580779 | Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in Escherichia coli |
Q34245546 | Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. |
Q96137182 | Ethical considerations of gene editing and genetic selection |
Q29616645 | Evolution and classification of the CRISPR-Cas systems |
Q26740457 | Evolutionary Ecology of Prokaryotic Immune Mechanisms |
Q33853796 | Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations |
Q38121774 | Exploiting CRISPR/Cas: interference mechanisms and applications. |
Q39431891 | Facilitation of CRISPR adaptation |
Q28072295 | Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems |
Q34314875 | Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems. |
Q35865998 | Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems. |
Q42376492 | Gene Editing in Rat Embryonic Stem Cells to Produce In Vitro Models and In Vivo Reporters. |
Q38846192 | Gene editing and its application for hematological diseases |
Q52371210 | Gene editing by CRISPR/Cas9 in the obligatory outcrossing Medicago sativa. |
Q37291177 | Generation of an ICF syndrome model by efficient genome editing of human induced pluripotent stem cells using the CRISPR system |
Q34657143 | Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system |
Q41968713 | Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus. |
Q38654840 | Genetics and Genomics of Cotton Leaf Curl Disease, Its Viral Causal Agents and Whitefly Vector: A Way Forward to Sustain Cotton Fiber Security |
Q92153117 | Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus |
Q37444262 | Genome engineering of mammalian haploid embryonic stem cells using the Cas9/RNA system |
Q41117712 | Genome-directed analysis of prophage excision, host defence systems, and central fermentative metabolism in Clostridium pasteurianum |
Q35771499 | Genome-wide RNA sequencing analysis of quorum sensing-controlled regulons in the plant-associated Burkholderia glumae PG1 strain. |
Q22065946 | Genomics and genetics of Sulfolobus islandicus LAL14/1, a model hyperthermophilic archaeon |
Q38979117 | Guide RNA engineering for versatile Cas9 functionality |
Q33791270 | Haloarcula hispanica CRISPR authenticates PAM of a target sequence to prime discriminative adaptation |
Q90298756 | Harnessing "A Billion Years of Experimentation": The Ongoing Exploration and Exploitation of CRISPR-Cas Immune Systems |
Q46235696 | High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences |
Q38122176 | Horizontal gene transfer in human pathogens |
Q94525902 | How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance |
Q45982664 | How bacteria control the CRISPR-Cas arsenal. |
Q47860478 | How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration. |
Q104577323 | Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine |
Q99237753 | Identification of a Type IV-A CRISPR-Cas System Located Exclusively on IncHI1B/IncFIB Plasmids in Enterobacteriaceae |
Q64263210 | Identification of a Xist silencing domain by Tiling CRISPR |
Q27496603 | Identification of novel growth phase- and media-dependent small non-coding RNAs in Streptococcus pyogenes M49 using intergenic tiling arrays |
Q30740166 | Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems |
Q37181661 | Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae |
Q37989572 | Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects. |
Q51827564 | Impact of CRIPSR immunity on the emergence of bacterial pathogens. |
Q38694026 | Impact of Different Target Sequences on Type III CRISPR-Cas Immunity |
Q35253340 | Impact of small repeat sequences on bacterial genome evolution. |
Q39094838 | In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex. |
Q42262732 | In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. |
Q28485452 | In vivo protein interactions and complex formation in the Pectobacterium atrosepticum subtype I-F CRISPR/Cas System |
Q27666877 | Interaction of the Cas6 Riboendonuclease with CRISPR RNAs: Recognition and Cleavage |
Q35108580 | Intertwined pathways of programmed cell death in immunity |
Q35536181 | Is the genetic landscape of the deep subsurface biosphere affected by viruses? |
Q36611501 | Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms |
Q91896952 | Kin discrimination in social yeast is mediated by cell surface receptors of the Flo11 adhesin family |
Q47723244 | Kinetics of dCas9 target search in Escherichia coli |
Q37827559 | Lateral genetic transfer and the construction of genetic exchange communities |
Q26800132 | Marine metagenomics as a source for bioprospecting |
Q34240056 | Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site |
Q27324547 | Mechanism of CRISPR-RNA guided recognition of DNA targets in Escherichia coli |
Q27678641 | Mechanism of Foreign DNA Selection in a Bacterial Adaptive Immune System |
Q39201233 | Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview |
Q41820341 | Microevolution in cyanobacteria: re-sequencing a motile substrain of Synechocystis sp. PCC 6803. |
Q34512535 | Mobile CRISPR/Cas-mediated bacteriophage resistance in Lactococcus lactis |
Q91254459 | Molecular mechanisms of CRISPR-Cas spacer acquisition |
Q27002658 | Molecular mechanisms of CRISPR-mediated microbial immunity |
Q34287113 | Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system |
Q21296736 | More than 200 genes required for methane formation from H₂ and CO₂ and energy conservation are present in Methanothermobacter marburgensis and Methanothermobacter thermautotrophicus |
Q90170474 | Multiplexed CRISPR technologies for gene editing and transcriptional regulation |
Q41761730 | Multiscale model of CRISPR-induced coevolutionary dynamics: diversification at the interface of Lamarck and Darwin |
Q34104619 | Nature and intensity of selection pressure on CRISPR-associated genes |
Q87066627 | Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity. |
Q38830837 | Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing |
Q33911242 | On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires |
Q40416750 | Overview of CRISPR-Cas9 Biology |
Q64962708 | PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures. |
Q59358470 | Phage Genetic Engineering Using CRISPR⁻Cas Systems |
Q33916703 | Phage encoded H-NS: a potential achilles heel in the bacterial defence system |
Q28729098 | Phage-induced expression of CRISPR-associated proteins is revealed by shotgun proteomics in Streptococcus thermophilus |
Q38720592 | Precise and efficient scarless genome editing in stem cells using CORRECT. |
Q41335264 | Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis. |
Q34042210 | Programmable RNA recognition and cleavage by CRISPR/Cas9. |
Q37079815 | Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis |
Q34400621 | Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems |
Q24632944 | Protospacer recognition motifs: mixed identities and functional diversity |
Q48340130 | RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex. |
Q36257710 | RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System |
Q42184018 | RNA in defense: CRISPRs protect prokaryotes against mobile genetic elements |
Q28649354 | RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus |
Q36603874 | RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex |
Q35064344 | RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions |
Q24630389 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems |
Q29614421 | RNA-guided genetic silencing systems in bacteria and archaea |
Q94522108 | Real-time observation of CRISPR spacer acquisition by Cas1-Cas2 integrase |
Q40348396 | Regulated CRISPR Modules Exploit a Dual Defense Strategy of Restriction and Abortive Infection in a Model of Prokaryote-Phage Coevolution |
Q90411044 | Regulation of Microbial Metabolic Rates Using CRISPR Interference With Expanded PAM Sequences |
Q90556101 | Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity |
Q28081298 | Resistance and tolerance to foreign elements by prokaryotic immune systems - curating the genome |
Q34621188 | Self-targeting by CRISPR: gene regulation or autoimmunity? |
Q103037446 | Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing |
Q26998827 | Small RNAs for defence and regulation in archaea |
Q34461590 | Small molecules enhance CRISPR genome editing in pluripotent stem cells. |
Q37518596 | Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease |
Q33741724 | Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates |
Q40051003 | Strategies for editing virulent staphylococcal phages using CRISPR-Cas10. |
Q45976671 | Strong bias in the bacterial CRISPR elements that confer immunity to phage. |
Q42595828 | Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family |
Q34175461 | Structural basis for CRISPR RNA-guided DNA recognition by Cascade |
Q27703998 | Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli |
Q50914568 | Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System |
Q90021362 | Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference |
Q27676627 | Structure and Mechanism of the CMR Complex for CRISPR-Mediated Antiviral Immunity |
Q37394423 | Structure of an RNA silencing complex of the CRISPR-Cas immune system. |
Q41980729 | Structure of the CRISPR interference complex CSM reveals key similarities with cascade |
Q27677966 | Structure of the Cmr2 Subunit of the CRISPR-Cas RNA Silencing Complex |
Q39022294 | Suppressing the CRISPR/Cas adaptive immune system in bacterial infections |
Q28079111 | Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications |
Q34394269 | TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery. |
Q34494161 | Target motifs affecting natural immunity by a constitutive CRISPR-Cas system in Escherichia coli. |
Q42630018 | Targeted Large-Scale Deletion of Bacterial Genomes Using CRISPR-Nickases |
Q35274944 | Targeted bacterial immunity buffers phage diversity |
Q51148515 | The Biology of CRISPR-Cas: Backward and Forward |
Q36461912 | The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease |
Q42793079 | The CRISPR/Cas immune system is an operon regulated by LeuO, H-NS, and leucine-responsive regulatory protein in Salmonella enterica serovar Typhi. |
Q42363720 | The Escherichia coli CRISPR system protects from λ lysogenization, lysogens, and prophage induction |
Q52422560 | The bacterial CRISPR/Cas system as analog of the mammalian adaptive immune system. |
Q38315561 | The eukaryotic way to defend and edit genomes by sRNA-targeted DNA deletion |
Q46482246 | The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome. |
Q43017770 | The immune system of halophilic archaea. |
Q28296787 | The phage-host arms race: shaping the evolution of microbes |
Q59357210 | The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems |
Q33608753 | The small, slow and specialized CRISPR and anti-CRISPR of Escherichia and Salmonella |
Q35561686 | The structural biology of CRISPR-Cas systems |
Q38757432 | Therapeutic genome engineering via CRISPR-Cas systems |
Q41950756 | Transcription, processing and function of CRISPR cassettes in Escherichia coli |
Q34988030 | Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition |
Q40076533 | Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems. |
Q90025180 | Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity |
Q90689982 | Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants |
Q41898322 | Unexpectedly broad target recognition of the CRISPR-mediated virus defence system in the archaeon Sulfolobus solfataricus |
Q33960829 | Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems |
Q34041195 | Unravelling the structural and mechanistic basis of CRISPR-Cas systems |
Q36222658 | Use of single molecule sequencing for comparative genomics of an environmental and a clinical isolate of Clostridium difficile ribotype 078. |
Q35491742 | Viral ancestors of antiviral systems |
Q36454957 | Viral diversity threshold for adaptive immunity in prokaryotes |
Q35677508 | Virus-induced dormancy in the archaeon Sulfolobus islandicus |
Q41715206 | When Competing Viruses Unify: Evolution, Conservation, and Plasticity of Genetic Identities |
Q35895874 | When ribonucleases come into play in pathogens: a survey of gram-positive bacteria |
Search more.